Celldex Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript

Sep 26, 2023 / 05:00PM GMT
Kristen Kluska - Cantor Fitzgerald, L.P. - Analyst

All right. Good afternoon, everybody. Welcome to the afternoon session of the Cantor Healthcare Conference. Really happy to be with the Celldex team. We have Anthony Marucci, CEO; Dr. Diego Alvarado, Executive Director of Research; and Dr. Diane Young, CMO.

Thank you all so much for coming. I really appreciate it.

Diego Alvarado - Celldex Therapeutics, Inc. - Executive Director of Research

Thank you for inviting us. Glad to see you again.

Kristen Kluska - Cantor Fitzgerald, L.P. - Analyst

Yes. So our conference is well timed to this year because you have two data readouts expected before year end. After the success of your healthy volunteer and urticaria studies, we're going to see the first look at barzo, and a new indication, prurigo nodularis.

Questions and Answers:

Kristen Kluska - Cantor Fitzgerald, L.P. - Analyst

To set the stage, why you believe this indication is relevant for mast cell targeting?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot